Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan
· Delayed Price · Currency is TWD 37.95
+0.30 (0.80%)
Sep 10, 2024, 1:30 PM CST
Synmosa Biopharma Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 9, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 16,115 | 14,706 | 16,021 | 7,016 | 6,814 | 5,638 | Upgrade
|
| Market Cap Growth | 1.05% | -8.20% | 128.36% | 2.96% | 20.87% | 7.93% | Upgrade
|
| Enterprise Value | 18,088 | 17,100 | 19,459 | 10,892 | 11,385 | 9,771 | Upgrade
|
| Last Close Price | 37.95 | 34.62 | 39.07 | 16.92 | 16.12 | 14.21 | Upgrade
|
| PE Ratio | 23.24 | 23.65 | 19.18 | 22.11 | 9.74 | 106.09 | Upgrade
|
| PS Ratio | 3.08 | 2.86 | 3.65 | 2.17 | 2.24 | 2.10 | Upgrade
|
| PB Ratio | 2.31 | 1.82 | 2.41 | 1.15 | 1.14 | 1.17 | Upgrade
|
| P/FCF Ratio | 61.59 | 48.24 | 31.98 | 19.39 | 68.14 | -24.70 | Upgrade
|
| P/OCF Ratio | 29.60 | 28.73 | 25.42 | 15.42 | 26.78 | -125.61 | Upgrade
|
| EV/Sales Ratio | 3.49 | 3.33 | 4.44 | 3.37 | 3.75 | 3.65 | Upgrade
|
| EV/EBITDA Ratio | 18.21 | 18.43 | 25.58 | 22.83 | 25.99 | 68.91 | Upgrade
|
| EV/EBIT Ratio | 27.56 | 27.72 | 42.24 | 58.33 | 76.15 | -92.03 | Upgrade
|
| EV/FCF Ratio | 69.14 | 56.09 | 38.84 | 30.10 | 113.85 | -42.81 | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.30 | 0.50 | 0.57 | 0.62 | 0.67 | Upgrade
|
| Debt / EBITDA Ratio | 2.49 | 2.56 | 4.32 | 7.15 | 8.30 | 21.45 | Upgrade
|
| Debt / FCF Ratio | 9.57 | 7.98 | 6.70 | 9.57 | 37.02 | -14.11 | Upgrade
|
| Asset Turnover | 0.42 | 0.45 | 0.41 | 0.31 | 0.32 | 0.33 | Upgrade
|
| Inventory Turnover | 1.87 | 1.99 | 1.97 | 1.59 | 1.74 | 2.14 | Upgrade
|
| Quick Ratio | 1.42 | 1.33 | 1.10 | 0.95 | 0.94 | 0.58 | Upgrade
|
| Current Ratio | 2.22 | 2.14 | 1.73 | 1.64 | 1.91 | 1.05 | Upgrade
|
| Return on Equity (ROE) | 6.21% | 5.49% | 9.71% | 1.93% | 8.82% | -3.07% | Upgrade
|
| Return on Assets (ROA) | 3.39% | 3.36% | 2.68% | 1.13% | 0.98% | -0.82% | Upgrade
|
| Return on Capital (ROIC) | 3.83% | 3.75% | 2.94% | 1.21% | 1.06% | -0.89% | Upgrade
|
| Earnings Yield | 4.30% | 4.04% | 4.99% | 4.33% | 9.36% | 0.84% | Upgrade
|
| FCF Yield | 1.62% | 2.07% | 3.13% | 5.16% | 1.47% | -4.05% | Upgrade
|
| Dividend Yield | 1.45% | 1.58% | 1.28% | 2.26% | 1.25% | - | Upgrade
|
| Payout Ratio | 28.22% | 32.69% | 18.60% | 26.32% | 7.16% | 80.73% | Upgrade
|
| Buyback Yield / Dilution | -7.65% | -3.87% | 0.79% | -2.35% | -9.76% | 9.42% | Upgrade
|
| Total Shareholder Return | -6.20% | -2.29% | 2.07% | -0.09% | -8.50% | 9.42% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.